GeneDx Investors Face August Deadline in Securities Fraud Lawsuit

The lawsuit, filed by the Rosen Law Firm, centers on claims that GeneDx executives misled shareholders about the financial benefits of the Fabric purchase. During the class period, the company repeatedly suggested that the acquisition would reduce costs and optimize dry lab processes. According to the complaint, these assurances were false, as management either knew of or recklessly disregarded significant operational problems within Fabric that threatened the company's bottom line.

Investors who incurred losses following the disclosure of these issues may be eligible for compensation. While a class has not yet been certified, those affected can participate by retaining counsel or remaining as absent class members. Serving as a lead plaintiff involves directing the litigation, though it is not a requirement for sharing in potential future recoveries. Interested parties are directed to contact Phillip Kim at the Rosen Law Firm to review the case details and filing requirements before the August deadline.